Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.33 million.

GUIDANCE:

Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.23 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.